Brand name authorized in:
The drug ADADUT contains
one active pharmaceutical ingredient (API):
Dutasteride reduces circulating levels of dihydrotestosterone (DHT) by inhibiting both type 1 and type 2, 5α-reductase isoenzymes which are responsible for the conversion of testosterone to DHT.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification
system as follows: